Developing a whole-plant therapeutic, AMZ0026, that exhibits immunomodulator properties for the treatment of HIV/AIDS. Preliminary clinical studies in patients that are seropositive for HIV-1 have demonstrated a positive effect on CD4 and CD4/CD8 blood serum levels.
Start Trial Get Full Profile
There’s no risk. Start your trial today to see profiles of Amazon Biotech (OTCBB: AMZB) plus 4860 other startups.